Ecopharmacostewardship-A pharmaceutical industry perspective

Green and Sustainable Pharmacy

Volumn , Issue , 2010, Pages 105-126

  Taylor, David ^a  

^a WCA ENVIRONMENT LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84879972900     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-05199-9_7     Document Type: Chapter

References (38)

1. Alder AC, Bruchet A, Carballa MC, Clara M, Joss A, Löffler CS, McArdell KM, Miksch K, Omil F, Tuhkanen T, Ternes T (2006) Consumption & occurrence. In: Ternes T and Joss A (eds.) Human Pharmaceuticals, Hormones and Fragrances-The Challenge of Micropollutants in Urban Water Management. IWA Publishing, London, pp. 15-54
2. Anastas PT, Warner JC (1998) Green Chemistry: Theory and Practice. Oxford University Press, Oxford
3. Anon (2005) Environmentally Classified Pharmaceuticals. Stockholm County Council
4. Anon (2007a) Environmental classification of pharmaceuticals in www.fass.se : guidance for pharmaceutical companies, January 2007. Swedish Association of the Pharmaceutical Industry Stockholm
5. Anon (2007b) Product Stewardship Institute Web: http://www. productstewardship.us/displaycommon.cfm?an=1&subarticlenbr=55
6. AstraZeneca (2008) Responsibility-Climate Change. Web: http://www.astrazeneca.com
7. Boxall A, Brooks B, Backhaus T, Gouy D, Hickman S, Kidd K, Metcalfe C, Monteiro S, Netherton M, Parrot J, Smith E, Straub JO, Weeks J (2008) Ecotoxicology of pharmaceuticals: Making sense of the published literature. EU Framework 6 Project KNAPPE Deliverable number: D4.1. Report of the WP4 Workshop; 28-31 January, 2008, Harrogate, UK
8. BristolMyers Squibb (2007) Land Use & Biodiversity. Web: http://www.bms.com/ehs/perfor/data/landus.html
9. Clarke J, Summerton L (2010) Challenges and opportunities for incorporating green chemistry into drug design to minimise environmental impact. (In press)
10. Crow JM (2008) Pharma goes green to cut costs. Chemistry World, July 2008
11. Cunningham VL, Buzby M, Hutchinson TH, Mastrocco F, Parke N, Roden N (2006) Effects of human pharmaceuticals on aquatic life: Next steps. Environ Sci Technol 40, 3457-3462
12. Curzons AD, Constable DC, Cunningham VL (1999) Solvent selection guide: A guide to the integration of environmental, health and safety criteria into the selection of solvents. Clean Products Process 1, 82-90
13. Daughton CG (2003) Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health Part I: Rationale for and avenues towards a green pharmacy. Environ Health Perspect, May 2003
14. Dunn P, Wells A, Williams MT (2010) Green Chemistry in the Pharmaceutical Industry. Wiley, Germany
15. EC (2000) Directive 2000/60/ec of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy. Official Journal L327 22/12/2000: 1-72
16. EC (2004) Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal L136 30/04/2004: 34-57
17. EMEA (2007) Guideline on the environmental risk assessment of medicinal products for human use. European medicines Evaluation Agency Guidance Note EMEA/CHMP/SWP/4447/00. Web: http://www.emea.europa.eu/pdfs/human/swp/444700en. pdf
18. EPA (2008) Presidential Green Chemistry Challenge 2008. Web: http://www.epa.gov/gcc/pubs/pgcc/presgcc.html
19. GlaxoSmithKline (2007) Answering the questions that matter. Corporate Responsibility Report 2007. Web: http://www.gsk.com/reportsandpublications.htm
20. Halling-Sørensen B, Nielsen SN, Lanzky PF, Ingerslev F, Holten-Lützhøft HC, Jørgensen SE (1998) Occurrence, Fate and Effects of Pharmaceutical Substances in the Environment: A Review. Chemosphere 36, 357-393
21. IFPMA (2008) Web: http://www.ifpma.org/index.php?id=600
22. Kümmerer K (ed.) (2004) Pharmaceuticals in the Environment. 2nd edition, Springer-Verlag, New York
23. Kümmerer K (2007) Sustainable from the very beginning: rational design of molecules by lifecycle engineering as an important approach for green pharmacy and green chemistry. Green Chem 9, 899-907
24. Kümmerer K, Al-Ahmad A, Bertram B,WießlerM(2000) Biodegradability of antineoplastic compounds in screening tests: Influence of glucosidation and of stereochemistry. Chemosphere 40, 767-773
25. Larsson DGL, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Hazard Mater 148(3), 751-755
26. Mattson B, Näsman I, Ström J (2007) Sweden's voluntary drug environmental classification system. RAJ Pharma, 153-158
27. ONDCP (2007) Proper Disposal of Prescription Drugs. US Office of National Drug Control Policy, Washington, DC. Web: http://www.whitehousedrugpolicy.gov/
28. Owen SF, Giltrow E, Huggett DB, Hutchinson TH, Saye J,Winter MJ, Sumpter JP (2007) Review: Comparative physiology, pharmacology and toxicology of ß-blockers: Mammals versus fish. Aquat Toxicol 82, 145-162
29. Pfizer (2007) Water Use & Conservation. Web: http://www.pfizer.com/ responsibility/ehs/conserving-water-performance.jsp
30. PwC (2007) Pharma 2020: The Vision. Which Path Will You Take? PriceWaterHouse Coopers, London
31. Ramessar K, Capell T, Christou P (2008) Molecular pharming in cereal crops. Phytochem Rev 7, 579-592
32. Richardson ML, Bowron JM (1985) The fate of pharmaceutical chemicals in the aquatic environment. J Pharm Pharmacol 37, 1-12
33. Ruhoy IS, Daughton CG (2008) Beyond the medicine cabinet: An analysis of why & where medications accumulate. Environ Int 34, 1157-1169
34. Sheldon RA (1994) Consider the Environmental Quotient. Chemtech 24, 38-47
35. Stan HJ, Heberer T, Linkerhägner M (1994) Occurrence of clofibric acid in the aquatic system-does the medical application cause contamination of surface, ground and drinking water? Vom Wasser 83, 57-68
36. Taylor D, Poulmaire M (2008) An initial survey of unused & expired medicine take-back schemes in the European Union. Poster Presentation Pharmaceutical Products in the Environment: Towards Lowering Occurrence and Impact KNAPPE International Conference. Nimes (France)
37. Thomas KV, Dye C, Schlabach M, Langford KH (2007) Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Monit 9, 1410-1418
38. United Nations (2002) Convention on the Conservation of Biological Diversity. Web: http://www.biodiv.org/convention/default.shtml